1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Influenza Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Influenza Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Influenza Vaccines Market Regional Analysis
6.2 Middle East & Africa Influenza Vaccines Market Revenue 2020-2028 (US$ Million)
6.3 Middle East & Africa Influenza Vaccines Market Forecast Analysis
7. Middle East & Africa Influenza Vaccines Market Analysis – by Vaccine Type
7.1 Quadrivalent Vaccines and Trivalent Vaccines
- 7.1.1 Overview
- 7.1.2 Quadrivalent Vaccines and Trivalent Vaccines: Middle East & Africa Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Middle East & Africa Influenza Vaccines Market Analysis – by Virus Type
8.1 Influenza Virus Type A and Influenza Virus Type B
- 8.1.1 Overview
- 8.1.2 Influenza Virus Type A and Influenza Virus Type B: Middle East & Africa Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Middle East & Africa Influenza Vaccines Market Analysis – by Technology
9.1 Egg-based and Cell-based
- 9.1.1 Overview
- 9.1.2 Egg-based and Cell-based: Middle East & Africa Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. Middle East & Africa Influenza Vaccines Market Analysis – by Route of Administration
10.1 Injection and Nasal Spray
- 10.1.1 Overview
- 10.1.2 Injection and Nasal Spray: Middle East & Africa Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
11. Middle East & Africa Influenza Vaccines Market – Middle East and Africa Analysis
11.1 Overview
11.2 Middle East and Africa
- 11.2.1 Middle East & Africa Influenza Vaccines Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 11.2.1.1 Middle East & Africa Influenza Vaccines Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 South Africa:
Middle East & Africa Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 South Africa: Middle East & Africa Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.1.2 South Africa: Middle East & Africa Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.1.3 South Africa: Middle East & Africa Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.1.4 South Africa: Middle East & Africa Influenza Vaccines Market Breakdown, by Route of Administration
- 11.2.1.2 Saudi Arabia:
Middle East & Africa Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Saudi Arabia: Middle East & Africa Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.2.2 Saudi Arabia: Middle East & Africa Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.2.3 Saudi Arabia: Middle East & Africa Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.2.4 Saudi Arabia: Middle East & Africa Influenza Vaccines Market Breakdown, by Route of Administration
- 11.2.1.3 UAE:
Middle East & Africa Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 UAE: Middle East & Africa Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.3.2 UAE: Middle East & Africa Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.3.3 UAE: Middle East & Africa Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.3.4 UAE: Middle East & Africa Influenza Vaccines Market Breakdown, by Route of Administration
- 11.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Influenza Vaccines Market Breakdown, by Route of Administration
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 AstraZeneca
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 GlaxoSmithKline plc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Mitsubishi Chemical Group Corporation
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 MYLAN N.V.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Sanofi
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 SEQIRUS
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Serum Institute of India Pvt. Ltd
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For Middle East & Africa Influenza Vaccines Market
